In recent years, it has become widely accepted that breast cancer can be classified into multiple subtypes by immunohistochemical (IHC) analysis of the estrogen receptor (ER), progesterone receptor (PgR), HER-2, and Ki-67. This evidence concerns the gene PGR and breast cancer.